• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION PRISMAFLEX MACHINES; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION PRISMAFLEX MACHINES; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Catalog Number 955685
Device Problem Filling Problem (1233)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/21/2023
Event Type  malfunction  
Event Description
It was reported that during treatment with a prismaflex machine, the calcium syringe pump had a higher flow rate than programmed.The calcium levels increased (noted via laboratory testing) and therapy was discontinued.The event occurred during continuous renal replacement therapy (crrt) in which a 10% calcium gluconate solution is used and the machine is programmed with the same solution.There was no report of patient injury or medical intervention associated with this event.No additional information is available.
 
Manufacturer Narrative
Initial reporter address - (b)(6).The device was not received for evaluation; however, it was inspected on-site by a baxter qualified technician.Visual inspection did not identify any abnormalities that could have contributed to the reported condition.The baxter technician checked prescription and prepared solutions and carried out an assessment the device.The technician also evaluated the external part of the machine, housing, display, connectors, hooks, pedestal, casters, power cord, scales, bubble detector ar, syringe holder, and the wrench pump handle.The technician checked the syringe clip setup, and everything was found to be within product specification ranges.Simulated therapy was performed for twenty-five minutes and was found to be functioning properly.The reported condition was not verified during functional testing.A review of the log file revealed that the prismaflex calcium delivery was set for a calcium concentration 223 mmol/l; while the reporter stated the concentration of the calcium solution, they used during the treatment was calcium gluconate with calcium concentration 680 mmol/l.Usual calcium gluconate solutions are in the range around 230 mmol/l, while solution concentrations in the range of 660-680 mmol/l are typical of the calcium chloride solutions.The reported condition was not verified during functional testing; however, there is a discrepancy between calcium concentration set and actual calcium concentration of the solution.This could potentially cause an over-delivery of ionic calcium to the patient¿s blood due to a user error.The prismaflex ifu requires (ref.Prismaflex operator manual, section 8.5.7, anticoagulation methods, safety system) that in case of citrate-calcium anticoagulation therapy a procedure of periodical advisory checkpoints shall be observed during the treatment.This advisory reminds an additional monitoring of patient¿s blood parameter through periodical blood chemical analysis in order to mitigate the risk of calcium over- or under-delivery.A service history review revealed no indication that the parts replaced during servicing caused or contributed to the reported event.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRISMAFLEX MACHINES
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
Manufacturer (Section G)
BAXTER HEALTHCARE - LUND MONITORS
magistratsvagen 16
lund skane lan 22643
SW   22643
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 60073
2242702068
MDR Report Key16404932
MDR Text Key310232759
Report Number9616026-2023-00009
Device Sequence Number1
Product Code KDI
UDI-Device Identifier07332414125547
UDI-Public(01)07332414125547
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Other
Type of Report Initial
Report Date 02/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number955685
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/23/2023
Initial Date FDA Received02/20/2023
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
10% CALCIUM GLUCONATE SOLUTION.
-
-